top of page
PRRT MASTERCLASS
2020
AND
2021
LUTATHERA® Prescribing information
Technical Issue?
Peptide receptor radionuclide therapy (PRRT) for the management of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
These PRRT masterclasses have been organised and funded by Advanced Accelerator Applications, a Novartis company
bottom of page